Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials

Sponsor
University of Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT02020252
Collaborator
Northwestern University (Other), Merck Sharp & Dohme LLC (Industry)
120
1
60.2
2

Study Details

Study Description

Brief Summary

The purpose of this research study is to test a touchscreen computer program, which allows patients to see information on a computer screen regarding cancer care, and specifically clinical trials. The purpose of this research is to help the investigators learn more about how to use technology in the medical setting to improve health outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Testing an interactive technology in a diverse health literary population

Detailed Description

Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. The purpose of this project is to pilot a multi-media technology intervention designed for patients with diverse health literacy skills with the aim of improving patient receptiveness, willingness, knowledge, self-efficacy, and positive attitudes regarding clinical trials. The intervention is comprised of multi-media touchscreen computer program components for clinical trial education and assessment of patient-reported outcomes. Patients presenting for their first oncology appointment were eligible. Patients viewed an interactive teaching video concerning clinical trials that was adapted from the National Institutes of Health. Validated surveys assessing receptiveness, willingness, knowledge, self-efficacy, and positive attitudes regarding clinical trials were administered before and after the test.

Study Design

Study Type:
Observational
Actual Enrollment :
120 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
A Pilot Investigation to Examine the Effect of a Multi-Media, Computer Based Tool (Talking Touchscreen) on Enrollment in Adult Oncology-Specific Clinical Trials at an Academic Medical Center
Actual Study Start Date :
Nov 26, 2013
Actual Primary Completion Date :
Dec 1, 2018
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Touchscreen Participants

New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system.

Behavioral: Testing an interactive technology in a diverse health literary population
Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.

Outcome Measures

Primary Outcome Measures

  1. Clinical Trials Attitudes, Knowledge, and Interest [Immediately after the visit.]

    We hypothesized that our interactive educational tool would improve patient receptivity, willingness, knowledge, self-efficacy and positive attitudes regarding therapeutic cancer clinical trials through the use of patient-friendly technology in the immediate pre-visit period. Patients used the TT to self-administer 24 items from the Clinical Trial questionnaire developed by Jacobsen and colleagues measuring Receptivity (range: 1-5), Willingness (range: 1-5), Knowledge about cancer clinical trials (range: 0-6), Positive Attitudes toward clinical trials (range: 1-5), and Self-Efficacy (range: 1-5). A high score for each subscale represents a more favorable outcome.

Secondary Outcome Measures

  1. Evaluate the Feasibility and Acceptability of Multi-media Technology. [Immediately after the visit.]

    Secondary objectives of the study were to evaluate the feasibility and acceptability of multi-media technology for patient-reported outcomes (PRO) assessment and patient education in an oncology clinic. This was evaluated with a semi-structured interview with participants.

  2. Clinical Trial Participation [About 6 months after the interview with participant.]

    We used medical record abstraction to determine how many participants discussed clinical trials with their providers, how many were offered a clinical trial and how many were enrolled in a clinical trial.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult, English-speaking women and men

  • Newly diagnosed with lung, gastric or pancreatic cancer

  • Coming to the University of Chicago outpatient oncology clinics for their first oncology visit

There are no Exclusion Criteria.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Chicago Comprehensive Cancer Center Chicago Illinois United States 60637

Sponsors and Collaborators

  • University of Chicago
  • Northwestern University
  • Merck Sharp & Dohme LLC

Investigators

  • Principal Investigator: Blase Polite, MD, University of Chicago Comprehensive Cancer Center

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
University of Chicago
ClinicalTrials.gov Identifier:
NCT02020252
Other Study ID Numbers:
  • IRB13-1233
First Posted:
Dec 24, 2013
Last Update Posted:
Mar 10, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Chicago

Study Results

Participant Flow

Recruitment Details New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system.
Pre-assignment Detail
Arm/Group Title Touchscreen Participants
Arm/Group Description New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system. Testing an interactive technology in a diverse health literary population: Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.
Period Title: Overall Study
STARTED 120
COMPLETED 120
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Touchscreen Participants
Arm/Group Description Testing Interactive Technology
Overall Participants 120
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
99
82.5%
>=65 years
21
17.5%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
62.8
(11.7)
Sex: Female, Male (Count of Participants)
Female
39
32.5%
Male
81
67.5%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
3
2.5%
Not Hispanic or Latino
116
96.7%
Unknown or Not Reported
1
0.8%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
20
16.7%
White
96
80%
More than one race
0
0%
Unknown or Not Reported
4
3.3%
Region of Enrollment (Count of Participants)
United States
120
100%
Clinical Trials Attitudes, Knowledge, and Interest (units on a scale) [Mean (Full Range) ]
Receptivity
4.7
Willingness
4.1
Knowledge
3.3
Positive Attitudes
3.6
Self-efficacy
4.1
PROMIS (T-score) [Mean (Standard Deviation) ]
Companionship
56.4
(7.2)
Instrumental Support
59.5
(6.8)
Physical Health
48.4
(7.6)
Mental Health
46.1
(10.2)
Health Literacy (t-score) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [t-score]
59.2
(8.9)

Outcome Measures

1. Primary Outcome
Title Clinical Trials Attitudes, Knowledge, and Interest
Description We hypothesized that our interactive educational tool would improve patient receptivity, willingness, knowledge, self-efficacy and positive attitudes regarding therapeutic cancer clinical trials through the use of patient-friendly technology in the immediate pre-visit period. Patients used the TT to self-administer 24 items from the Clinical Trial questionnaire developed by Jacobsen and colleagues measuring Receptivity (range: 1-5), Willingness (range: 1-5), Knowledge about cancer clinical trials (range: 0-6), Positive Attitudes toward clinical trials (range: 1-5), and Self-Efficacy (range: 1-5). A high score for each subscale represents a more favorable outcome.
Time Frame Immediately after the visit.

Outcome Measure Data

Analysis Population Description
New lung, gastric and pancreatic cancer patients.
Arm/Group Title Touchscreen Participants
Arm/Group Description New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system. Testing an interactive technology in a diverse health literary population: Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.
Measure Participants 120
Receptivity
4.6
Willingness
3.9
Knowledge
4.9
Positive Attitude
3.7
Self-Efficacy
4.3
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Touchscreen Participants
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value .307
Comments This is for the receptivity sub-scale, and the comparison between pre and post-test scores.
Method t-test, 2 sided
Comments This was a paired t-test.
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Touchscreen Participants
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value .009
Comments This is for the willingness sub-scale, and the comparison between pre and posttest scores.
Method t-test, 2 sided
Comments This was a paired t-test.
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Touchscreen Participants
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value <.001
Comments This is for knowledge sub scale, and the comparison between pre and posttest scores.
Method t-test, 2 sided
Comments A paired t-test.
Statistical Analysis 4
Statistical Analysis Overview Comparison Group Selection Touchscreen Participants
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value .004
Comments This is for the positive attitudes sub scale, and the comparison between pre and posttest scores.
Method t-test, 2 sided
Comments This was a paired t-test.
Statistical Analysis 5
Statistical Analysis Overview Comparison Group Selection Touchscreen Participants
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value <.001
Comments This was for the self-efficacy sub scale, and the comparison between pre and posttest scores.
Method t-test, 2 sided
Comments This was a paired t-test.
2. Secondary Outcome
Title Evaluate the Feasibility and Acceptability of Multi-media Technology.
Description Secondary objectives of the study were to evaluate the feasibility and acceptability of multi-media technology for patient-reported outcomes (PRO) assessment and patient education in an oncology clinic. This was evaluated with a semi-structured interview with participants.
Time Frame Immediately after the visit.

Outcome Measure Data

Analysis Population Description
A few people were not able to participate in the interviews.
Arm/Group Title Touchscreen Participants
Arm/Group Description New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system. Testing an interactive technology in a diverse health literary population: Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.
Measure Participants 109
Difficulty using the touchscreen-not at all, a little bit
102
85%
Overall rating of screen design-very good, excellent
73
60.8%
Have you used a computer within the past 12 mo-yes
98
81.7%
Have you ever used a touchscreen before-yes
100
83.3%
Difficulty using the touchscreen to view the video or learning program-not at all
99
82.5%
Overall rating of video-very good, excellent
77
64.2%
Overall rating of learning program-very good, excellent
78
65%
Did the video help you to better understand clinical trials-somewhat, quite a bit
100
83.3%
Did the learning program (NC) help you to better understand clinical trials-somewhat, quite a bit
94
78.3%
Overall rating of the amount of time you spent on this study, about right
96
80%
Rate your experience participating-a little better, a lot better than expected
61
50.8%
3. Secondary Outcome
Title Clinical Trial Participation
Description We used medical record abstraction to determine how many participants discussed clinical trials with their providers, how many were offered a clinical trial and how many were enrolled in a clinical trial.
Time Frame About 6 months after the interview with participant.

Outcome Measure Data

Analysis Population Description
The percentages are based on the population described in the row titles.
Arm/Group Title Touchscreen Participants
Arm/Group Description New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system. Testing an interactive technology in a diverse health literary population: Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.
Measure Participants 120
Discussed clinical trials with a physician
63
52.5%
Offered a clinical trial among those who reported a discussion
38
31.7%
Enrolled in a clinical trial among those offered a clinical trial
48
40%

Adverse Events

Time Frame Not applicable to this study.
Adverse Event Reporting Description Death and other serious and non-serious events were not collected.
Arm/Group Title Touchscreen Participants
Arm/Group Description New lung, gastric and pancreatic cancer patients presenting to the University of Chicago outpatient oncology clinics, a large research institution located on Chicago's Southside, were identified for study accrual, using the electronic scheduling system. Testing an interactive technology in a diverse health literary population: Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.
All Cause Mortality
Touchscreen Participants
Affected / at Risk (%) # Events
Total 0/0 (NaN)
Serious Adverse Events
Touchscreen Participants
Affected / at Risk (%) # Events
Total 0/0 (NaN)
Other (Not Including Serious) Adverse Events
Touchscreen Participants
Affected / at Risk (%) # Events
Total 0/0 (NaN)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Toni M Cipriano
Organization University of Chicago Medicine
Phone 574-339-0652
Email tcipriano@uchicago.edu
Responsible Party:
University of Chicago
ClinicalTrials.gov Identifier:
NCT02020252
Other Study ID Numbers:
  • IRB13-1233
First Posted:
Dec 24, 2013
Last Update Posted:
Mar 10, 2021
Last Verified:
Mar 1, 2021